BetterLife Pharma Inc
BetterLife Pharma Inc. is an emerging biotechnology company based in Dollard-Des Ormeaux, Quebec, dedicated to developing and commercializing patient-friendly therapeutics for neuropsychiatric and neurological disorders. Their innovative approach aims to produce non-hallucinogenic medicines that address a wide range of unmet mental health conditions, including anxiety, depression, and PTSD.
The company's lead product, BETR001, is a second-generation LSD derivative designed to mimic the therapeutic properties of LSD without its hallucinogenic side effects. By focusing on evidence-driven solutions, BetterLife Pharma strives to provide effective treatments for debilitating psychiatric disorders and severe neurological conditions, ultimately aiming to enhance the quality of life for patients.
Generated from the website
You might also like
Partial Data by Infogroup (c) 2023. All rights reserved.